Page last updated: 2024-10-15

2-keto-4-methylvalerate and Fatty Liver, Nonalcoholic

2-keto-4-methylvalerate has been researched along with Fatty Liver, Nonalcoholic in 1 studies

alpha-ketoisocaproic acid: RN given refers to parent cpd
4-methyl-2-oxopentanoate : A 2-oxo monocarboxylic acid anion that is the conjugate base of 4-methyl-2-oxopentanoic acid.
4-methyl-2-oxopentanoic acid : A 2-oxo monocarboxylic acid that is pentanoic acid (valeric acid) substituted with a keto group at C-2 and a methyl group at C-4. A metabolite that has been found to accumulate in maple syrup urine disease.

Research Excerpts

ExcerptRelevanceReference
"77 patients with NAFLD and 11 healthy control subjects were studied."1.48The characterisation of hepatic mitochondrial function in patients with non-alcoholic fatty liver disease (NAFLD) using the ( Afolabi, PR; Almehmadi, AA; Byrne, CD; Calder, PC; Scorletti, E; Smith, DE, 2018)
"HMF (cPDR over 1 h) was lower in NAFLD compared to controls [13."1.48The characterisation of hepatic mitochondrial function in patients with non-alcoholic fatty liver disease (NAFLD) using the ( Afolabi, PR; Almehmadi, AA; Byrne, CD; Calder, PC; Scorletti, E; Smith, DE, 2018)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Afolabi, PR1
Scorletti, E1
Smith, DE1
Almehmadi, AA1
Calder, PC1
Byrne, CD1

Other Studies

1 other study available for 2-keto-4-methylvalerate and Fatty Liver, Nonalcoholic

ArticleYear
The characterisation of hepatic mitochondrial function in patients with non-alcoholic fatty liver disease (NAFLD) using the
    Journal of breath research, 2018, 07-19, Volume: 12, Issue:4

    Topics: Adult; Breath Tests; Carbon Isotopes; Case-Control Studies; Diabetes Mellitus, Type 2; Female; Human

2018